Cargando…
Weight Considerations in Pharmacotherapy for Type 2 Diabetes
Obesity has been increasing in prevalence worldwide and the majority of patients with type 2 diabetes are either overweight or obese. Diabetes management in this population has been difficult since a number of antidiabetes agents are associated with weight gain. The effects of various antidiabetes a...
Autores principales: | Cheng, Vicky, Kashyap, Sangeeta R. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2946585/ https://www.ncbi.nlm.nih.gov/pubmed/20885921 http://dx.doi.org/10.1155/2011/984245 |
Ejemplares similares
-
Cancer Risk in Type 2 Diabetes Mellitus: Metabolic Links and Therapeutic Considerations
por: Sun, Grace, et al.
Publicado: (2011) -
Pharmacotherapy considerations with finerenone in the treatment of chronic kidney disease associated with type 2 diabetes
por: Ashjian, Emily, et al.
Publicado: (2023) -
Preventive pharmacotherapy in type 2 diabetes mellitus
por: Choudhary, Neeraj, et al.
Publicado: (2012) -
Body Weight Considerations in the Management of Type 2 Diabetes
por: Apovian, Caroline M., et al.
Publicado: (2018) -
Neuropsychiatric Symptoms in Dementia: Considerations for Pharmacotherapy in the USA
por: Phan, Stephanie V., et al.
Publicado: (2019)